ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,108.42
0.34%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) Noticias

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BNTC
FechaHoraFuenteTítuloSímboloCompañía
08/03/202415:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
08/03/202415:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
05/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
26/02/202408:06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
23/02/202415:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
13/02/202407:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
17/11/202307:00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
13/11/202307:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
20/10/202315:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
20/10/202305:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
21/09/202307:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
21/09/202307:00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
11/08/202312:00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
10/08/202315:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
08/08/202321:30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
07/08/202307:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
25/07/202312:00GlobeNewswire Inc.Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023NASDAQ:BNTCBenitec Biopharma Limited
07/07/202315:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
26/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BNTCBenitec Biopharma Limited
26/06/202307:00GlobeNewswire Inc.Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNASDAQ:BNTCBenitec Biopharma Limited
15/06/202315:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202307:00GlobeNewswire Inc.Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
08/05/202307:05GlobeNewswire Inc.Benitec Biopharma to Present at the OPMD International ConferenceNASDAQ:BNTCBenitec Biopharma Limited
08/05/202307:00GlobeNewswire Inc.Benitec Biopharma to Present at the JMP Securities Life Sciences ConferenceNASDAQ:BNTCBenitec Biopharma Limited
18/04/202315:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BNTCBenitec Biopharma Limited
13/02/202307:00GlobeNewswire Inc.Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
23/01/202308:48GlobeNewswire Inc.Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development ProgramNASDAQ:BNTCBenitec Biopharma Limited
13/12/202205:04Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BNTCBenitec Biopharma Limited
10/11/202207:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

Su Consulta Reciente

NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
FX
USDMXN
US Dollar vs MXN
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados